---
figid: PMC8431732__ijms-22-09592-g002
figtitle: Nrf2/ARE Pathway and Its Role in Neurodegenerative Diseases
organisms:
- Panax ginseng
- Curcuma longa
- Citrus x paradisi
- Schisandra chinensis
- Mus musculus
- Rattus norvegicus
- Homo sapiens
pmcid: PMC8431732
filename: ijms-22-09592-g002.jpg
figlink: /pmc/articles/PMC8431732/figure/ijms-22-09592-f002/
number: F2
caption: Transcriptional, posttranscriptional and posttranslational regulation of
  Nrf2 activity. The transcription of Nr2 is regulated by the transcription factors,
  oncogenes (KRAS, Myc, Jun) and modifications of the Nrf2 promoter (hypermethylation
  or SNPs). Posttranscriptional regulation includes alternative splicing and microRNA
  binding. The posttranslational control of Nrf2 activity results from protein modifications,
  protein degradation and protein–protein interactions. Arrows and blunt ends indicate
  activation and inhibition, respectively. ROS, reactive oxygen species; SNPs, single
  nucleotide polymorphisms; Akt, serine/threonine-protein kinase; BRCA1, breast cancer
  susceptibility 1; PI3K, phosphoinositide 3-kinase; NF-κB, nuclear factor-κB; AhR,
  aryl hydrocarbon receptor; Fyn, tyrosine-protein kinase Fyn; GSK-3, glycogen synthase
  kinase-3; pGSK-3, phosphorylated glycogen synthase kinase-3; KRAS, GTPase KRas;
  Myc, Myc proto-oncogene protein; Jun, transcription factor AP-1; AP-2, activating
  enhancer-binding protein 2; Sp1, specificity protein 1; PKC, protein kinase C; CK-2,
  casein kinase 2; β-TrCP, β-transducin repeat-containing protein; Hrd1, HMG-CoA reductase
  degradation 1; WDR23, WD-repeat protein 23; PGAM5, phosphoglycerate mutase 5; DPP3,
  dipeptidyl peptidase 3; WTX, Wilms tumor gene on the X chromosome; PALB2, partner
  and localizer of BRCA2; p21, cyclin-dependent kinase inhibitor 1; p62/SQSTM1, sequestosome
  1. Figure adapted from [].
papertitle: An Overview of the Nrf2/ARE Pathway and Its Role in Neurodegenerative
  Diseases.
reftext: Emilia Zgorzynska, et al. Int J Mol Sci. 2021 Sep;22(17):9592.
year: '2021'
doi: 10.3390/ijms22179592
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: MDPI
keywords: Nrf2 | Keap1 | oxidative stress | neuroprotection | neurodegenerative diseases
  | Alzheimer’s disease | Parkinson’s disease | Huntington’s disease | amyotrophic
  lateral sclerosis
automl_pathway: 0.8537757
figid_alias: PMC8431732__F2
figtype: Figure
organisms_ner:
- Homo sapiens
- Mus musculus
- Rattus norvegicus
redirect_from: /figures/PMC8431732__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8431732__ijms-22-09592-g002.html
  '@type': Dataset
  description: Transcriptional, posttranscriptional and posttranslational regulation
    of Nrf2 activity. The transcription of Nr2 is regulated by the transcription factors,
    oncogenes (KRAS, Myc, Jun) and modifications of the Nrf2 promoter (hypermethylation
    or SNPs). Posttranscriptional regulation includes alternative splicing and microRNA
    binding. The posttranslational control of Nrf2 activity results from protein modifications,
    protein degradation and protein–protein interactions. Arrows and blunt ends indicate
    activation and inhibition, respectively. ROS, reactive oxygen species; SNPs, single
    nucleotide polymorphisms; Akt, serine/threonine-protein kinase; BRCA1, breast
    cancer susceptibility 1; PI3K, phosphoinositide 3-kinase; NF-κB, nuclear factor-κB;
    AhR, aryl hydrocarbon receptor; Fyn, tyrosine-protein kinase Fyn; GSK-3, glycogen
    synthase kinase-3; pGSK-3, phosphorylated glycogen synthase kinase-3; KRAS, GTPase
    KRas; Myc, Myc proto-oncogene protein; Jun, transcription factor AP-1; AP-2, activating
    enhancer-binding protein 2; Sp1, specificity protein 1; PKC, protein kinase C;
    CK-2, casein kinase 2; β-TrCP, β-transducin repeat-containing protein; Hrd1, HMG-CoA
    reductase degradation 1; WDR23, WD-repeat protein 23; PGAM5, phosphoglycerate
    mutase 5; DPP3, dipeptidyl peptidase 3; WTX, Wilms tumor gene on the X chromosome;
    PALB2, partner and localizer of BRCA2; p21, cyclin-dependent kinase inhibitor
    1; p62/SQSTM1, sequestosome 1. Figure adapted from [].
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TFAP2A
  - SP1
  - PSG1
  - DAND5
  - MYC
  - KRAS
  - NRAS
  - JUN
  - JUNB
  - JUND
  - NFKB1
  - AHR
  - GABPA
  - NFE2L2
  - FYN
  - KEAP1
  - GSK3A
  - GSK3B
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - CDKN1A
  - TCEAL1
  - NSG1
  - H3P16
  - PGAM5
  - DPP3
  - AMER1
  - PALB2
  - SQSTM1
  - GTF2H1
  - KHDRBS1
  - NUP62
  - DCTN4
  - BRCA1
  - BTRC
  - SYVN1
  - DCAF11
  - CSNK2A1
  - CSNK2A2
  - CSNK2B
  - Tfap2a
  - Sp1
  - Myc
  - Nol3
  - Kras
  - Jun
  - Nfkb1
  - Ahr
  - Nfe2l2
  - Fyn
  - Keap1
  - Gsk3b
  - Cdkn1a
  - Nsg1
  - Tpt1
  - Tceal1
  - Pgam5
  - Dpp3
  - Amer1
  - Palb2
  - Sqstm1
  - Gtf2h1
  - Nup62
  - Khdrbs1
  - Dctn4
  - Brca1
  - Btrc
  - Syvn1
  - Dcaf11
  - Csnk2a1
  - Csnk2a2
  - Fabp4
  - Th
  - Prkcg
  - Csnk2b
---
